Reconsidering T component of cancer staging for T3/T4 non-small-cell lung cancer with additional nodule.

Ther Adv Med Oncol · 2022 · PMC9597052 · PMID 36312817

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

In the independent cohort, T3-Add patients had a comparable prognosis with T2b patients ( p = 0.703) and a better prognosis than T3 patients ( p = 0.053), although the difference failed to reach significance due to relatively small sample size ( Supplemental Figure 6 ).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.